StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > 500k bid at 0.10 and 360k ask at 0.24 on the us otc

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Oct 19, 2024 5:30pm

77 Views

Post# 36273349

RE:RE:RE:500k bid at 0.10 and 360k ask at 0.24 on the us otc

" Can't wait for the tsx to open...".
News flash - the tsx has been open for every trading day for the last SIX months.

It is SZLS that is halted. Details matter.

You really don't know the difference do you?

Jonnyboy85 wrote: The bid and the ask both threw out tiny fills to bait the other into moving, fun to watch. Can't wait for the tsx to open and see what all the fuss is about with this news

<< Previous

Bullboard Posts

Next >>

Apolo IV Acquisition and Marviken Ontario sign merger agreement